Aerosol therapy for obstructive lung diseases: Device selection and practice management issues

Chest

Volumn 140, Issue 3, 2011, Pages 781-788

  Sims, Michael W ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARFORMOTEROL; AZTREONAM; BECLOMETASONE; BUDESONIDE PLUS FORMOTEROL; CICLESONIDE; DORNASE ALFA; FLUNISOLIDE; FLUTICASONE; FLUTICASONE PROPIONATE PLUS SALMETEROL; FORMOTEROL; FORMOTEROL FUMARATE PLUS MOMETASONE FUROATE; IPRATROPIUM BROMIDE; IPRATROPIUM BROMIDE PLUS SALBUTAMOL SULFATE; ISOPRENALINE; LEVALBUTEROL; ORCIPRENALINE; PENTAMIDINE; PIRBUTEROL; RIBAVIRIN; SALBUTAMOL; SALMETEROL; TIOTROPIUM BROMIDE; TOBRAMYCIN; TRIAMCINOLONE; UNCLASSIFIED DRUG;

AEROSOL; AIRWAY; BILLING AND CLAIMS; CHRONIC OBSTRUCTIVE LUNG DISEASE; DEVICE; DRUG CHOICE; DRUG CONCENTRATION; DRUG DELIVERY SYSTEM; DRUG TOXICITY; MEDICAL INFORMATION; MEDICAL INFORMATION SYSTEM; MEDICAL NEBULIZER; METERED DOSE INHALER; PNEUMOCYSTIS PNEUMONIA; POWDER INHALER; PRIORITY JOURNAL; REVIEW;

EID: 80052659829     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.10-2068     Document Type: Review

References (36)

1. Global strategy for diagnosis, management, and prevention of COPD. Global Initiative for Chronic Obstructive Lung Disease Web site. http://www.goldcopd. org. Updated 2010. Accessed August 11, 2010.
2. Global strategy for asthma management and prevention. Global Initiative for Asthma Web site. http://www.ginasthma.org. Updated 2009. Accessed August 11, 2010.
3. Flume PA, O'Sullivan BP, Robinson KA, et al Cystic Fibrosis Foundation, Pulmonary Therapies Committee. Cystic fibrosis pulmonary guidelines: chronic medications for maintenance of lung health. Am J Respir Crit Care Med. 2007;176(10):957-969. (Pubitemid 350127838)
4. Pasteur MC, Bilton D, Hill AT; British Thoracic Society Bronchiectasis non-CF Guideline Group. British Thoracic Society guideline for non-CF bronchiectasis. Thorax. 2010;65(suppl 1):i1-i58.
5. Dolovich MB, Ahrens RC, Hess DR, et al American College of Chest Physicians; American College of Asthma, Allergy, and Immunology. Device selection and outcomes of aerosol therapy: Evidence-based guidelines: American College of Chest Physicians/American College of Asthma, Allergy, and Immunology. Chest. 2005;127(1):335-371. (Pubitemid 41724594)
6. Lenney J, Innes JA, Crompton GK. Inappropriate inhaler use: assessment of use and patient preference of seven inhalation devices. EDICI. Respir Med. 2000;94(5):496-500. (Pubitemid 30353008)
7. Melani AS, Zanchetta D, Barbato N, et al Associazione Italiana Pneumologi Ospedalieri Educational Group. Inhalation technique and variables associated with misuse of conventional metered-dose inhalers and newer dry powder inhalers in experienced adults. Ann Allergy Asthma Immunol. 2004;93(5):439-446. (Pubitemid 39507710)
8. Kelling JS, Strohl KP, Smith RL, Altose MD. Physician knowledge in the use of canister nebulizers. Chest. 1983;83(4):612-614. (Pubitemid 13109735)
9. Newman SP, Pavia D, Clarke SW. How should a pressurized beta-adrenergic bronchodilator be inhaled? Eur J Respir Dis. 1981;62(1):3-21.
10. Drugs@FDA: FDA approved drug products. US Food and Drug Administration Web site. http://www.accessdata.fda.gov/scripts/cder/drugsatfda. Published 2010. Accessed July 29, 2010.
11. Newman SP. Spacer devices for metered dose inhalers. Clin Pharmacokinet. 2004;43(6):349-360. (Pubitemid 38594710)
12. Barry PW, O'Callaghan C. The effect of delay, multiple actuations and spacer static charge on the in vitro delivery of budesonide from the Nebuhaler. Br J Clin Pharmacol. 1995;40(1):76-78.
13. Wildhaber JH, Devadason SG, Eber E, et al. Effect of electrostatic charge, flow, delay and multiple actuations on the in vitro delivery of salbutamol from different small volume spacers for infants. Thorax. 1996;51(10):985-988. (Pubitemid 26360172)
14. Hess D. Delivery of inhaled medication in adults. In: Basow DS, ed. UpToDate. Waltham, MA: UpToDate; 2010.
15. Cobben NA, Drent M, Jonkers M, Wouters EF, Vaneechoutte M, Stobberingh EE. Outbreak of severe Pseudomonas aeruginosa respiratory infections due to contaminated nebulizers. J Hosp Infect. 1996;33(1):63-70. (Pubitemid 26178983)
16. Waldrep JC, Dhand R. Advanced nebulizer designs employing vibrating mesh/aperture plate technologies for aerosol generation. Curr Drug Deliv. 2008;5(2):114-119. (Pubitemid 351536317)
17. Chavan V, Dalby R. Effect of rise in simulated inspiratory flow rate and carrier particle size on powder emptying from dry powder inhalers. AAPS PharmSci. 2000;2(2):E10. http://www.aapsj.org/view.asp?art=ps020210.
18. Epstein S, Maidenberg A, Hallett D, Khan K, Chapman KR. Patient handling of a dry-powder inhaler in clinical practice. Chest. 2001;120(5):1480-1484. (Pubitemid 33078461)
19. Public health advisory: important information on the correct use of Spiriva and Foradil capsules. US Food and Drug Administration Web site. http://www.fda.gov/Drugs/DrugSafety/ PostmarketDrugSafetyInformationforPatientsandProviders/ DrugSafetyInformationforHeathcareProfessionals/PublicHealthAdvisories/ucm051132. html. Published February 29, 2008. Accessed July 30, 2010.
20. Allen SC. Competence thresholds for the use of inhalers in people with dementia. Age Ageing. 1997;26(2):83-86. (Pubitemid 27241281)
21. Pedersen S, Frost L, Arnfred T. Errors in inhalation technique and efficiency in inhaler use in asthmatic children. Allergy. 1986;41(2):118-124. (Pubitemid 16044352)
22. Patient instructions for inhaled devices in English and Spanish. American College of Chest Physicians Web site. http://www.chestnet.org/accp/patient- guides/patient-instructions-inhaled-devices-english-and-spanish. Accessed December 22, 2010.
23. Newman SP, Weisz AW, Talaee N, Clarke SW. Improvement of drug delivery with a breath actuated pressurised aerosol for patients with poor inhaler technique. Thorax. 1991;46(10):712-716.
24. Khine H, Fuchs SM, Saville AL. Continuous vs intermittent nebulized albuterol for emergency management of asthma. Acad Emerg Med. 1996;3(11):1019-1024. (Pubitemid 26372967)
25. Papo MC, Frank J, Thompson AE. A prospective, randomized study of continuous versus intermittent nebulized albuterol for severe status asthmaticus in children. Crit Care Med. 1993;21(10):1479-1486. (Pubitemid 23312481)
26. Dhand R, Tobin MJ. Inhaled bronchodilator therapy in mechanically ventilated patients. Am J Respir Crit Care Med. 1997;156(1):3-10. (Pubitemid 27293159)
27. Coates AL, MacNeish CF, Lands LC, Meisner D, Kelemen S, Vadas EB. A comparison of the availability of tobramycin for inhalation from vented vs unvented nebulizers. Chest. 1998;113(4):951-956. (Pubitemid 28216437)
28. Campbell PW III, Saiman L. Use of aerosolized antibiotics in patients with cystic fibrosis. Chest. 1999;116(3):775-788. (Pubitemid 29428499)
29. Pulmozyme (dornase alfa) inhalation solution [package insert]. San Francisco, CA: Genentech, Inc; 2005.
30. McCoy KS, Quittner AL, Oermann CM, Gibson RL, Retsch-Bogart GZ, Montgomery AB. Inhaled aztreonam lysine for chronic airway Pseudomonas aeruginosa in cystic fibrosis. Am J Respir Crit Care Med. 2008;178(9):921-928.
31. Current Procedural Terminology. American Medical Association Web site. https://catalog.ama-assn.org. Accessed December 22, 2010.
32. Manaker S, Krier-Morrow D, Pohlig C, eds. Coding for Chest Medicine 2011: Pulmonary, Critical Care, Sleep. 15th ed. Northbrook, IL: American College of Chest Physicians; 2011.
33. Transmittal R954CP: payment for evaluation and management services provided during global period of surgery. Department of Health and Human Services, Centers for Medicare and Medicaid Services Web site. https://www.cms.gov/transmittals/downloads/R954CP.pdf. Accessed August 5, 2010.
34. Pohlig C. Exercise-induced bronchospasm: coding and billing for physician services. Chest. 2009;135(1):210-214.
35. Peters SG. Office services. In: Manaker S, Krier-Morrow D, Pohlig C, eds. Coding for Chest Medicine 2011: Pulmonary, Critical Care, Sleep. Northbrook, IL: American College of Chest Physicians; 2011:199-210.
36. American Medical Association/Specialty Society Relative Value System Update Committee Database. Chicago, IL: American Medical Association; 2010.